Reported cumulative MMR rate of 47% (25 of 53) by 24 weeks with 32% (13 of 41) of patients achieving MMR by 24 weeks, which continues to compare favorably to precedent ...

Reported cumulative MMR rate of 47% (25 of 53) by 24 weeks with 32% (13 of 41) of patients achieving MMR by 24 weeks, which ...

Viruses closely related to the deadly MERS coronavirus are lurking in bats and one group, known as HKU5, may be just one mutation away from making the jump to humans. A new study reveals how these ...

A new COVID-19 variant called NB.1.8.1, aka "Nimbus," is spreading rapidly in the United States, CDC data show. What to know ...

Robust responses observed across subgroups, regardless of co-mutations, number of prior lines of therapy, or prior venetoclax, within efficacy-evaluable pivotal R/R mNPM1 AML population – – 60% (3/5) ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Vaccine critics among new ACIP ...

The World Health Organization (WHO) is keeping an eye on a new COVID-19 variant called NB.1.8.1, or “Nimbus,” that has spread across Europe, the Americas and the Western Pacific.

Health officials are tracking a highly contagious new COVID-19 variant. This comes as confusion grows over vaccine ...

Genetics and poor healthcare contribute to Black men's prostate cancer disparities. Unequal care, not biology, is the root ...

Data show SPR301 lowered α-synuclein, a hallmark of Parkinson’s disease, in cellular models, indicating potential for efficacy at doses with favorable safety ...

A ctDNA-guided approach can help identify when patients with HR-positive advanced breast cancer are developing an ESR1 ...

Gene therapies, exon-skipping drugs and next-gen steroids are reshaping Duchenne muscular dystrophy care, targeting broader ages and mutations. We are witnessing the fastest pivot in rare-disease ...